Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant

Posttransplant vaccination targeting residual disease is an immunotherapeutic strategy to improve antigen-specific immune responses and prolong disease-free survival after autologous stem cell transplantation (ASCT) for multiple myeloma (MM). We conducted a phase 1 vaccine trial to determine the saf...

Celý popis

Podrobná bibliografia

Vydané v:	Blood advances Ročník 6; číslo 5; s. 1547 - 1558
Hlavní autori:	Chung, David J., Sharma, Sneh, Rangesa, Madhumitha, DeWolf, Susan, Elhanati, Yuval, Perica, Karlo, Young, James W.
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States Elsevier Inc 08.03.2022 American Society of Hematology
Predmet:	Antigens, Neoplasm Autografts Cancer Vaccines - adverse effects Clinical Trials and Observations Dendritic Cells Hematopoietic Stem Cell Transplantation Humans Lenalidomide Multiple Myeloma RNA, Messenger - genetics Transplantation, Autologous
ISSN:	2473-9529, 2473-9537, 2473-9537
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!